0001179110-12-012652.txt : 20120809
0001179110-12-012652.hdr.sgml : 20120809
20120809190040
ACCESSION NUMBER: 0001179110-12-012652
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120807
FILED AS OF DATE: 20120809
DATE AS OF CHANGE: 20120809
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Aguiar Michael W
CENTRAL INDEX KEY: 0001318005
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30319
FILM NUMBER: 121022012
MAIL ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: THERAVANCE INC
CENTRAL INDEX KEY: 0001080014
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943265960
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6508086000
MAIL ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: S. SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MEDICINE INC
DATE OF NAME CHANGE: 20000302
4
1
edgar.xml
FORM 4 -
X0306
4
2012-08-07
0
0001080014
THERAVANCE INC
THRX
0001318005
Aguiar Michael W
THERAVANCE, INC.
901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Sr VP, Chief Financial Officer
Common Stock
2012-08-07
4
M
0
60000
16.25
A
217924
D
Common Stock
2012-08-07
4
S
0
60000
27.04
D
157924
D
Stock Option (Right to Buy)
16.25
2012-08-07
4
M
0
60000
0
D
2018-07-22
Common Stock
60000
0
D
Dispositions made pursuant to a plan intended to comply with rule 10b5-1(c).
This transaction was executed in multiple trades at prices ranging from $26.60 to $27.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
Immediately exercisable.
Michael W. Aguiar
2012-08-09